ORGANOGENESIS INC. for ORGANOGENESIS INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Health Issues HCR
FDA policy on chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.